| 产品详情 |
| Edit |   |
|---|
| Product Name | Orlistat |
|---|
| Description | Purity ≥98% (HPLC). Hypolipemic cell permeable and irreversible pancreatic, gastric and carboxylester lipase inhibitor. Anti-obesity and antihypercholesterolemic compound. Antitumor compound by inhibition of the thioesterase domain of fatty acid synthase (FASN). Anti-proliferative. Causes cell cycle arrest at G1 phase. Apoptosis inducer through caspase-3 activation. Sn-1-selective-diacylglycerol lipases alpha (DAGLalpha) inhibitor. Targets serine hydrolases in the nervous system, such as diacylglycerol lipase (DAGL), which is responsible for the conversion of DAG to 2-AG. Partially inhibits the hydrolysis of triglycerides and lowers the absorption of dietary fat, promoting weight loss. Promotes the sensitivity to TRAIL in cancer cells by ROS-mediated pathways. Source: Synthetic. Originally isolated from Streptomyces sp. Synonyms: Tetrahydrolipstatin; Xenical; Alli; Ro-18-0647 |
|---|
| Size | 50mg, 250mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | Tetrahydrolipstatin; Xenical; Alli; Ro-18-0647 |
|---|
| Gene, Accession, CAS # | CAS: 96829-58-2 |
|---|
| Catalog # | 45122 |
|---|
| Price | |
|---|
| Order / More Info | Orlistat from UNITED STATES BIOLOGICAL |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|